You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
拋棄兩大醫藥愛股,近70億重倉這家公司,“千億頂流”張坤最新調倉出爐
格隆匯 10-26 09:47

本文來自:上海證券報,作者:陸海晴

三季度,公募“千億頂流”張坤調倉動作頻頻,目前已有百億持倉浮出水面。具體來看,張坤管理的易方達藍籌精選加倉海康威視3400萬股,截至三季度末的持股市值達到68.2億元。

而在大舉加倉海康威視、平安銀行等個股的同時,張坤正在拋棄他的“舊愛”,三季度大幅減持“牙茅”通策醫療、“眼茅”愛爾眼科。

值得一提的是,張坤最近親自參加了海康威視的調研,這場調研活動還吸引了多位百億級基金經理參加。

張坤押注海康威視

減倉愛爾眼科

張坤對海康威視的愛始於去年四季度。去年年底,易方達藍籌精選成為海康威視新晉前十大流通股東,持股數量為7000萬股,今年一季度又加倉2000萬股。在三季度進一步加倉3400萬股後,最新持股數量已達到1.24億股。

從海康威視表現來看,去年10月初至今年1月底,其股價漲幅超過60%,此後則持續處於震盪盤整狀態。

對待醫藥股,張坤的態度則較為謹慎。

10月25日晚間,愛爾眼科公佈的三季報顯示,張坤管理的易方達藍籌精選已退出公司前十大流通股東之列,這意味着其至少減倉1300多萬股。值得注意的是,二季度,易方達藍籌精選曾加倉愛爾眼科1501萬股。從愛爾眼科股價表現來看,二季度漲幅超55%,三季度跌幅超過20%。

除了拋棄“眼茅”外,此前“牙茅”通策醫療的三季報顯示,張坤也已大幅減倉,其管理的易方達中小盤(現已更名為易方達優質精選)從通策醫療的前十大流通股東名單中退出,這意味着三季度至少減持了290萬股。

多位基金明星調研海康威視

除了用真金白銀押注,張坤還親自參加了“愛股”的調研活動。10月23日,在海康威視的線上業績説明會中,張坤罕見“露面”。

Choice數據顯示,今年以來,張坤只參加過5次上市公司調研,共調研過4家上市公司,分別是國際醫學、東鵬飲料、温氏股份、海康威視。

數據來源:Choice

除了張坤以外,此次海康威視的説明會還吸引了多位百億級基金經理親自參加,部分機構更是傾巢出動。

東證資管韓冬、王延飛,睿遠基金朱璘,興全基金喬遷、謝治宇、季文華,交銀施羅德基金郭斐、週中,平安基金李化松,以及同犇投資創始人童馴等均參與了調研。此外,高毅資產有張新河、姜思辰、劉丹、謝鵬宇、張繼楓、張陽等多人蔘與調研。

整體來看,機構較為關心外部環境對海康威視業績的影響。海康威視表示,目前智慧建築未來的業務開拓是依託於過去規模的快速增長,還是在存量的業務當中去做更多精細化的分析和管理,這是一個挑戰。

對於缺電帶來的影響,海康威視表示,就海康自己的工廠情況來看,目前投入產出以及對能耗需求之間的矛盾並沒有特別突出,還不屬於馬上會受到能源緊張威脅的產業。上游工廠中,有個別供應商現在已經面臨能源緊張的問題,他們的產能供給、交付時間可能都會因為能源供給緊張而沒有辦法保障。公司一方面還是會考慮增加庫存,另一方面會協調供應商的不同配置,包括增加備選供應商等。

不過,三季度以來,北向資金對海康威視進行了一定減持。截至10月22日,北向資金共持有海康威視7748.5萬股,較6月底減持2306.2萬股。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account